Skip to main content
Clinical Trials/NCT06100146
NCT06100146CompletedNot Applicable

Does Small Scale Cereal-based Fortification Hold the Key to Improved Micronutrient Status in Ethiopia? The Case of Folic Acid and Vitamin B12 in Teenage Girls in Arba Minch, Ethiopia

University Ghent2 sites in 1 country472 target enrollmentStarted: December 11, 2023Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
472
Locations
2
Primary Endpoint
General cognitive ability

Study Overview

Brief Summary

Folic acid and vitamin B12 play an interdependent role in key cellular processes, namely deoxyribonucleic acid synthesis, cell division, red blood cell formation, and nervous system myelination. A deficiency of either vitamin will predispose teenagers to many diseases, which persist across their lifespan. Fortification of food with micronutrients has been promoted to reduce micronutrient deficiencies. A large segment of vulnerable populations in low- and middle-income countries (LMICs) resides in rural settings and has limited access to large-scale commercialized fortified foods. In such operational constraints, the use of locally (small-scale) fortified cereals could be an alternative intervention. The study aims to evaluate the effectiveness of small scale folic acid and vitamin B12 fortified cereals in improving folate and vitamin B12 status, growth velocity, puberty status, anaemia, cognitive development and mental health among teenage girls, in rural rift valley of Ethiopia.

Detailed Description

Folic acid (FA) and vitamin B12 play an interdependent role in key cellular processes, namely deoxyribonucleic acid synthesis, cell division, red blood cell formation, and nervous system myelination. Teenagers are the future mothers. Hence their health and nutritional status have long term consequences on future pregnancies and birth outcomes. Neural Tube Defects (NTDs) are a group of fatal or severely disabling birth defects known to be mainly a consequence of severe folate deficiency in early pregnancy. The policy of advising women to take iron & FA (IFA) supplements during pregnancy has not been successful in preventing NTDs because of the low adherence to antenatal care services including IFA, the large proportion of unplanned pregnancies, the timing at which IFA supplementation starts, and the logistical limitation that makes the access to IFA limited. The evidence is strong on the importance of food fortification in the promotion of maternal and child health mainly through reducing micronutrient deficiencies. A large segment of vulnerable populations in developing countries resides in rural settings and has limited access to fortified foods in the market. In such operational constraints, using locally fortified cereals could be an alternative intervention. However, there is a paucity of evidence regarding effectiveness of small-scale cereal-based fortification; in Ethiopia, the evidence is inexistent. Moreover, teenage girls are an under-studied group and do not constitute a target population from different nutritional intervention programs.

The overall objective of this study is to evaluate the effectiveness of small-scale folic acid and vitamin B12-fortified cereals in improving folate and vitamin B12 status, growth velocity, puberty status, anaemia, cognitive development and mental health among rural teenage girls (13-19 years of age).

This study will be conducted in Arba Minch Health and Demographic Surveillance Sites (AM-HDSS), Southern Ethiopia from October 2023 to April 2024. Effectiveness of intake of folic acid and vitamin B12 fortified meals will be evaluated in a randomized, double-blind controlled trial among 474 teenage girls between 13 and 19 years of age who are residing in and attending one of the schools at AM-HDSS.

Data on the following variables, except for demographic characteristics of teenage girls and their respective parents and/or household heads will be collected at the start and end point of the 6 months intervention. Data collection will be carried out at schools and at respective girls' home.

  • Demographic characteristics of the teenage girls, morbidity status, helminthic infections, dietary intake, anthropometry, puberty status, presence of depressive symptoms, biochemical samples and cognitive development will be assessed in teenage girls directly at schools.
  • Socio-demographic characteristics of the parents or the head of the household if different from parents, family wealth status, food security, health care services and environmental characteristics will be collected in recruited teenage girls' households within the one week following the enrolment and at the end of the intervention.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Masking Description

Flours will be indistinguishable in appearance except for the vitamins added to the flours of the intervention group. An independent trained person will be assigned to monitor the fortification process and the two products will be packed immediately and coded.

Eligibility Criteria

Ages
13 Years to 19 Years (Child, Adult)
Sex
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Teenage girls between 13 and 19 years of age who live in households at Arba Minch Health and Demographic Surveillance Sites (AM-HDSS) are eligible to participate in the study if:
  • •One or both of their parents signed an informed consent form and the girl's agreement.
  • •Their parents and the girl planned to stay in the study area during the period of the study (minimum 6 months) in the kebele.
  • •Both parents and girls accept the intervention packages including blood draws and home visits.

Exclusion Criteria

  • •Chronically ill girls diagnosed with diabetes and asthma;
  • •Severely undernourished girls (defined as body mass index z score < -3 standard deviations of the median World Health Organization reference population);
  • •Severely anaemic girls (Hb concentration <80g/L);
  • •Teenage girls who are pregnant, lactating or taking IFA/B12 supplements;
  • •Diagnosed hemoglobinopathy (sickle cell or thalassemia);
  • •Diagnosed liver diseases like acute hepatitis, cirrhosis, hepatocellular carcinoma, and metastatic liver disease

Arms & Interventions

Control group

Placebo Comparator

Teenage girls randomly assigned to the control group will receive a standard bag of unfortified cereal flours every week for six months.

Intervention: Unfortified cereal flour (Other)

folic acid & vit B12 fortified flour

Experimental

Teenage girls randomly assigned to the control group will receive a standard bag of cereal flours fortified with folic acid and Vit B12 every week for six months.

Intervention: Folic acid and vitamin B12 fortified flour (Dietary Supplement)

Outcomes

Primary Outcomes

General cognitive ability

Time Frame: Assessed at 6 months

Raven Progressive Matrices (RPM) tests, a measure of nonverbal intelligence.

Depression

Time Frame: Assessed at 6 months

Depressive symptoms will be assessed by Patient Health Questionnaire (PHQ) 9 modified for adolescents (PHQ-9A), a self-report instrument comprised of 9-items. Items are rated on a four-point ordinal scale.

Fat-free mass

Time Frame: Assessed at 6 months

An index of adiposity will be measured to evaluate girls' body composition, in %

Erythrocyte (RBC) folic acid concentrations

Time Frame: Assessed at 6 months

RBC folate level ng/ml (nmol/l)

Working memory

Time Frame: Assessed at 6 months

Digit Span (Forward, Backward, and Sequencing) is a standardized test that assesses the working memory of participants.

Serum vitamin B12 concentrations

Time Frame: Assessed at 6 months

Serum vitamin B12 level (pmol/L)

Serum folic acid concentrations

Time Frame: Assessed at 6 months

Serum folate levels ng/ml (nmol/l)

Fat mass

Time Frame: Assessed at 6 months

An index of adiposity will be measured to evaluate girls' body composition, in kg

Secondary Outcomes

  • Height(Assessed at 6 months)
  • RBC structure (megaloblastic anaemia)(Assessed at 6 months)
  • Plasma homocysteine concentrations(Assessed at 6 months)
  • Weight(Assessed at 3 and 6 months)
  • Adherence to the intervention/fortification(Assessed weekly for the whole period of intervention (until 6 months))
  • Haemoglobin concentration(Assessed at 6 months)
  • Prevalence of soil-transmitted helminths(Assessed at 6 months)
  • Puberty status(Assessed at 6 months of fortification)
  • Prevalence of Schistosome infection(Assessed at 6 months)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials

Effectiveness of Fortification With Folic... | Clinical Trial